These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12132942)

  • 21. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
    Chiu-Tsao ST; Duckworth TL; Hsiung CY; Li Z; Williamson J; Patel NS; Harrison LB
    Med Phys; 2003 Jul; 30(7):1732-5. PubMed ID: 12906190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculated dosimetric parameters of the IoGold 125I source model 3631-A.
    Wierzbicki JG; Rivard MJ; Waid DS; Arterbery VE
    Med Phys; 1998 Nov; 25(11):2197-9. PubMed ID: 9829245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the dosimetric characteristics of InterSource125 iodine brachytherapy source.
    Meigooni AS; Yoe-Sein MM; Al-Otoom AY; Sowards KT
    Appl Radiat Isot; 2002 Apr; 56(4):589-99. PubMed ID: 11999157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantom.
    Wallace RE
    Med Phys; 2000 Dec; 27(12):2796-802. PubMed ID: 11190963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric study of the new Intersource125 iodine seed.
    Reniers B; Vynckier S; Scalliet P
    Med Phys; 2001 Nov; 28(11):2285-8. PubMed ID: 11764034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source.
    Meigooni AS; Gearheart DM; Sowards K
    Med Phys; 2000 Sep; 27(9):2168-73. PubMed ID: 11011747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source.
    Kirov AS; Williamson JF
    Med Phys; 2001 May; 28(5):764-72. PubMed ID: 11393471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric properties of the new 125I BrachySeed model LS-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Feb; 29(2):190-200. PubMed ID: 11865990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
    Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
    Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
    Abboud F; Hollows M; Scalliet P; Vynckier S
    Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
    DeMarco JJ; Hugo G; Solberg TD
    Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.